Cargando…
Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis
Atherosclerosis is the cause of the development of serious cardiovascular disorders, leading to disability and death. Numerous processes are involved in the pathogenesis of atherosclerosis, including inflammation, endothelial dysfunction, oxidative stress, and lipid metabolism disorders. Reverse tra...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836120/ https://www.ncbi.nlm.nih.gov/pubmed/35163256 http://dx.doi.org/10.3390/ijms23031332 |
_version_ | 1784649598667587584 |
---|---|
author | Poznyak, Anastasia V. Kashirskikh, Dmitry A. Sukhorukov, Vasily N. Kalmykov, Vladislav Omelchenko, Andrey V. Orekhov, Alexander N. |
author_facet | Poznyak, Anastasia V. Kashirskikh, Dmitry A. Sukhorukov, Vasily N. Kalmykov, Vladislav Omelchenko, Andrey V. Orekhov, Alexander N. |
author_sort | Poznyak, Anastasia V. |
collection | PubMed |
description | Atherosclerosis is the cause of the development of serious cardiovascular disorders, leading to disability and death. Numerous processes are involved in the pathogenesis of atherosclerosis, including inflammation, endothelial dysfunction, oxidative stress, and lipid metabolism disorders. Reverse transport of cholesterol is a mechanism presumably underlying the atheroprotective effect of high-density lipoprotein. In this review, we examined disorders of cholesterol metabolism and their possible effect on atherogenesis. We paid special attention to the reverse transport of cholesterol. Transformed cholesterol metabolism results in dyslipidemia and early atherosclerosis. Reverse cholesterol transport is an endogenous mechanism by which cells export cholesterol and maintain homeostasis. It is known that one of the main factors leading to the formation of atherosclerotic plaques on the walls of blood vessels are multiple modifications of low-density lipoprotein, and the formation of foam cells following them. |
format | Online Article Text |
id | pubmed-8836120 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88361202022-02-12 Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis Poznyak, Anastasia V. Kashirskikh, Dmitry A. Sukhorukov, Vasily N. Kalmykov, Vladislav Omelchenko, Andrey V. Orekhov, Alexander N. Int J Mol Sci Review Atherosclerosis is the cause of the development of serious cardiovascular disorders, leading to disability and death. Numerous processes are involved in the pathogenesis of atherosclerosis, including inflammation, endothelial dysfunction, oxidative stress, and lipid metabolism disorders. Reverse transport of cholesterol is a mechanism presumably underlying the atheroprotective effect of high-density lipoprotein. In this review, we examined disorders of cholesterol metabolism and their possible effect on atherogenesis. We paid special attention to the reverse transport of cholesterol. Transformed cholesterol metabolism results in dyslipidemia and early atherosclerosis. Reverse cholesterol transport is an endogenous mechanism by which cells export cholesterol and maintain homeostasis. It is known that one of the main factors leading to the formation of atherosclerotic plaques on the walls of blood vessels are multiple modifications of low-density lipoprotein, and the formation of foam cells following them. MDPI 2022-01-25 /pmc/articles/PMC8836120/ /pubmed/35163256 http://dx.doi.org/10.3390/ijms23031332 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Poznyak, Anastasia V. Kashirskikh, Dmitry A. Sukhorukov, Vasily N. Kalmykov, Vladislav Omelchenko, Andrey V. Orekhov, Alexander N. Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis |
title | Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis |
title_full | Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis |
title_fullStr | Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis |
title_full_unstemmed | Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis |
title_short | Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis |
title_sort | cholesterol transport dysfunction and its involvement in atherogenesis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836120/ https://www.ncbi.nlm.nih.gov/pubmed/35163256 http://dx.doi.org/10.3390/ijms23031332 |
work_keys_str_mv | AT poznyakanastasiav cholesteroltransportdysfunctionanditsinvolvementinatherogenesis AT kashirskikhdmitrya cholesteroltransportdysfunctionanditsinvolvementinatherogenesis AT sukhorukovvasilyn cholesteroltransportdysfunctionanditsinvolvementinatherogenesis AT kalmykovvladislav cholesteroltransportdysfunctionanditsinvolvementinatherogenesis AT omelchenkoandreyv cholesteroltransportdysfunctionanditsinvolvementinatherogenesis AT orekhovalexandern cholesteroltransportdysfunctionanditsinvolvementinatherogenesis |